China's Abbisko Cayman near 3-year peak on share buyback plan

Abbisko Medicine

04/03/2025 05:11

** Abbisko Cayman 2256.HK jumps 9.5% to HK$6.92, highest since June 2022

** Stock set for biggest one-day pct rise since February 20

** Chinese oncology therapies developer says it will buy back shares on-market for up to HK$200 mln ($25.73 mln), reflecting management's confidence in firm's operational growth outlook, financial position

** Stock up 48.7% YTD

($1 = HK$7.7743)

 (Reporting by Donny Kwok)

 ((donny.kwok@thomsonreuters.com))